Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks.
about
Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data.A comparative study of discriminating human heart failure etiology using gene expression profilesTranslational research of adult stem cell therapySRC-2 coactivator deficiency decreases functional reserve in response to pressure overload of mouse heartGata4 and Sp1 regulate expression of the erythropoietin receptor in cardiomyocytesComputational models reduce complexity and accelerate insight into cardiac signaling networksA multivariate approach for integrating genome-wide expression data and biological knowledgeA weighted average difference method for detecting differentially expressed genes from microarray data.Identification of gene co-regulatory modules and associated cis-elements involved in degenerative heart diseaseVisHiC--hierarchical functional enrichment analysis of microarray dataArrayInitiative - a tool that simplifies creating custom Affymetrix CDFsCardioprotection of controlled and cardiac-specific over-expression of A(2A)-adenosine receptor in the pressure overloadIncrease in GLUT1 in smooth muscle alters vascular contractility and increases inflammation in response to vascular injuryImpact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart.Sex and age dimorphism of myocardial gene expression in nonischemic human heart failure.Identification of differentially expressed transcripts and pathways in blood one week and six months following implant of left ventricular assist devices.Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failureFibroblast growth factor 2 is an essential cardioprotective factor in a closed-chest model of cardiac ischemia-reperfusion injuryTranscription factor GATA4 is activated but not required for insulin-like growth factor 1 (IGF1)-induced cardiac hypertrophyMechanotransduction Mechanisms for Intraventricular Diastolic Vortex Forces and Myocardial Deformations: Part 2.Clinical, molecular, and genomic changes in response to a left ventricular assist deviceGene expression profiling in human cardiovascular disease.Mechanisms of bone marrow-derived cell therapy in ischemic cardiomyopathy with left ventricular assist device bridge to transplantVentricular-assist devices for the treatment of chronic heart failure.Predict, prevent and personalize: Genomic and proteomic approaches to cardiovascular medicineBridge to recovery: understanding the disconnect between clinical and biological outcomes.Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action.Biodesign of a renal-protective peptide based on alternative splicing of B-type natriuretic peptide.Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support.Morphological and molecular changes of the myocardium after left ventricular mechanical supportA dynamic spatiotemporal extracellular matrix facilitates epicardial-mediated vertebrate heart regeneration.Cardiovascular genetic medicine: genomic assessment of prognosis and diagnosis in patients with cardiomyopathy and heart failureHold or fold--proteins in advanced heart failure and myocardial recovery.Docosahexaenoic acid reverses angiotensin II-induced RECK suppression and cardiac fibroblast migration.Building a bridge to recovery: the pathophysiology of LVAD-induced reverse modeling in heart failure.Clinical and Molecular Comparison of Pediatric and Adult Reverse Remodeling With Ventricular Assist Devices.Transcriptional patterns of reverse remodeling with left ventricular assist devices: a consistent signature.Molecular signature analysis: the potential of gene-expression analysis in cardiomyopathy.Ventricular arrhythmias after left ventricular assist device implantation.Decoding the noncoding transcripts in human heart failure.
P2860
Q24537656-F752064A-EF07-4EEC-9297-08E95443C46DQ24815374-1150572E-FDC3-4542-BA7F-AE692CBB5522Q26774565-790D30F0-2587-45C7-A431-AC3F0022CA7BQ27321625-1A7EC8C3-E4BC-45FC-86E8-CB8ADBFED025Q28587709-F7ABF364-AB93-4010-A1CC-E93478ABF962Q30428985-750DAB5B-D85B-4880-9A31-7B0ED4420CD6Q31050518-5C9D48AC-3CA1-46A2-8EB1-2418F931C0C4Q31160471-265C30E5-5D03-452F-B678-960F398FD03DQ33454995-1013D709-459B-4D44-A9D0-47AF82403E04Q33456627-9610C8D5-3500-4BE0-BB2A-E5E4A40F35D2Q33891517-1D9B5F35-7785-405F-B114-0B22315F3D4DQ34335762-126BD683-A1C8-4229-A746-147FE96D1ED7Q34459819-54B35795-882E-461C-A950-7C7EAB9E6C5DQ34641010-C96F0819-B202-431A-BC02-980111E7240FQ34961265-DDE069BA-BA7E-48E8-8CB2-B2D77916C8B9Q35035838-21739AF1-E224-4636-A870-8A5D454ED976Q35131260-F5365793-0D70-45A7-9890-2E5461170E5EQ35294164-A010039A-AA66-4911-97C2-167A4532E10EQ35880015-07B6582F-4CA2-451F-94FE-AFAE1752757DQ35901064-0A209CE7-A757-4F43-BFAA-60E8DCEB8FE2Q36054446-FA415601-6874-4DE9-9D52-2D63B3938879Q36277988-C190C2D3-CC3C-4A45-AF36-DED9468E52A7Q36630908-67574EB6-BAF9-4E51-91A5-F02C65A21360Q36815993-898EFCF7-7DF2-4284-AB1E-05E94860183BQ36898747-A1E8E222-4331-4840-90C7-80A3763DA0BBQ37021774-97C69DAD-A4F6-4759-BA7D-1A098920CB4AQ37021783-0B558B27-BFD9-4B8C-BE33-AD804D68B7E6Q37256856-039DD96B-5FFC-42E9-8035-37E44E61DC49Q37358790-19347168-C4DB-4724-9531-B0B8B7C39516Q37638247-39D044DC-F183-49F9-A754-CE35834E0B9FQ37642991-97733FBD-C5F2-4635-9EC3-43931169CB94Q37766146-384BD6F8-16E4-4E82-8CE7-7263C37F26E6Q38261514-8D1EFDE6-D7D3-4253-9CD2-7B618B782AEFQ38261562-17128B75-922D-45A6-8640-79EDA1C512B7Q38404844-BD019DF6-FB3D-4B35-A5B7-90E97A76204CQ38417459-207DD51A-7BA0-47BC-BAC1-39C86F2DC637Q38800048-71501C6A-4501-4944-8991-37754FE58C4CQ40377138-FD94BA40-5A9F-4BB0-889B-B4C7CE535509Q42569032-8ECF14DE-4F93-401C-A304-838295C3F5C9Q42637217-268C34F4-7CBF-4544-B2AD-BC56335E1BBC
P2860
Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Genomic profiling of the human ...... n vascular signaling networks.
@ast
Genomic profiling of the human ...... n vascular signaling networks.
@en
type
label
Genomic profiling of the human ...... n vascular signaling networks.
@ast
Genomic profiling of the human ...... n vascular signaling networks.
@en
prefLabel
Genomic profiling of the human ...... n vascular signaling networks.
@ast
Genomic profiling of the human ...... n vascular signaling networks.
@en
P2093
P1476
Genomic profiling of the human ...... in vascular signaling networks
@en
P2093
Ami Mariash
David Fermin
Jeanne Thompson
Jennifer L Hall
Judith Graziano
Leslie W Miller
Robert D Simari
Robert J Bache
Shireen E de Sam Lazaro
Shuchong Pan
P304
P356
10.1152/PHYSIOLGENOMICS.00004.2004
P50
P577
2004-05-19T00:00:00Z